Intensive Care Medicine

, Volume 32, Issue 8, pp 1206–1213 | Cite as

The prevalence and characteristics of anaemia at discharge home after intensive care

  • Timothy S. Walsh
  • Ezz-el-din Saleh
  • Robert J. Lee
  • D. Brian McClelland



To document the prevalence of anaemia among ICU survivors at the time of discharge home and to document red cell morphology among anaemic patients.

Design and setting

Observational cohort study in a single-centre teaching hospital.

Patients and participants

Three cohorts of ICU admissions over a 3-year period managed with restrictive ICU transfusion practice. The study group comprised the 283 patients who survived and were discharged directly home from our hospital.

Measurements and results

The median time from ICU discharge to hospital discharge was 13 days (IQR 6–22, range 1–119). Using the last recorded Hb concentration 77.4% (95% CI 72.2–82.1) of patients were anaemic, 32.5% (27.3–38.2) had Hb less than 100 g/l, and 11.3% (8.1–15.5) had Hb less than 90 g/l at hospital discharge. Patients who spent longer in intensive care and in hospital after ICU discharge were more likely to be discharged home anaemic. The strongest predictor of discharge home with Hb less than 100 g/l was Hb at the time of ICU discharge. Multivariate regression analysis showed patient age, gender, APACHE II score, and ICU length of stay not to be independent predictors after including the ICU discharge Hb. Among anaemic patients 82% had normochromic normocytic red cell indices, but 12% had red cell hypochromasia and/or microcytosis, which may indicate iron deficiency.


Anaemia is highly prevalent among survivors of critical illness and persists until hospital discharge. Most patients have red cell morphology similar to “anaemia of chronic disease”.


Blood Blood transfusion Epidemiology Critical illness Anaemia 

Supplementary material

134_2006_213_MOESM1_ESM.doc (24 kb)
Electronic Supplementary Material (DOC 25K)


  1. 1.
    Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417PubMedCrossRefGoogle Scholar
  2. 2.
    Cortesi E, Gastcon P, Henry D, Littlewood T, Milroy R, Pronzato P, Reinhardt U, Shasha D, Thatcher N, Wilkinson P (2005) Standard of care for cancer-related anaemia: improving hemoglobin levels and quality of life. Oncology 68 [Suppl 1]:22–32PubMedCrossRefGoogle Scholar
  3. 3.
    Rao M, Pereira BJ (2005) Optimal anemia management reduces cardiovascular morbidity, mortality, and costs of care in chronic kidney disease. Kidney Int 68:1432–1438PubMedCrossRefGoogle Scholar
  4. 4.
    Vasu S, Kelly P, Lawson WE (2005) Anemia in heart failure-a concise review. Clin Cardiol 28:454–458PubMedCrossRefGoogle Scholar
  5. 5.
    Walsh TS, Lee RJ, Maciver CR, Garrioch M, MacKirdy F, Binning AR, Cole S, McClelland DB, for the Audit of Transfusion in Intensive Care in Scotland (ATICS) study group (2006) Anaemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med 32:100–109PubMedCrossRefGoogle Scholar
  6. 6.
    Saleh E, McArdle F, Lee RJ, McClleland DBL, Walsh TS (2003) Prevalence of anaemia among survivors of critical illness managed with conservative transfusion triggers: a single centre cohort study. Br J Anaesth 90:819PGoogle Scholar
  7. 7.
    Saleh E, McClleland DBL, Walsh TS (2003) How prevalent is anaemia after ICU discharge: a prospective single centre cohort study? Intensive Care Med 29:S34Google Scholar
  8. 8.
    Chohan SS, McArdle F, McClelland DB, Mackenzie SJ, Walsh TS (2003) Red cell transfusion practice following the Transfusion Requirements in Critical Care (TRICC) study: prospective observational cohort study in a large UK intensive care unit. Vox Sang 84:211–218PubMedCrossRefGoogle Scholar
  9. 9.
    Walsh TS, Garrioch M, Maciver C, Lee RJ, MacKirdy F, McClelland DB, Kinsella J, Wallis C (2004) Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion 44:1405–1411PubMedCrossRefGoogle Scholar
  10. 10.
    Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ (2004) The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 32:39–52PubMedCrossRefGoogle Scholar
  11. 11.
    Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D (2002) Anemia and blood transfusion in critically ill patients. JAMA 288:1499–1507PubMedCrossRefGoogle Scholar
  12. 12.
    Pippard MJ, Hoffbrand AV (1990) Iron. In: Hoffbrand AV, Lewis SM (eds) Postgraduate haematology, 3rd edn. Heinemann, Oxford, pp 26–54Google Scholar
  13. 13.
    Goodnough LT, Skikne B, Brugnara C (2000) Erythropoietin, iron, and erythropoiesis. Blood 96:823–833PubMedGoogle Scholar
  14. 14.
    Bellamy MC, Gedney JA (1998) Unrecognised iron deficiency in critical illness. Lancet 352:1903PubMedCrossRefGoogle Scholar
  15. 15.
    Patteril MV, Davey-Quinn AP, Gedney JA, Murdoch SD, Bellamy MC (2001) Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesth Intensive Care 29:473–478PubMedGoogle Scholar
  16. 16.
    Piagnerelli M, Boudjeltia KZ, Brohee D, Piro P, Carlier E, Vincent JL, Lejeune P, Vanhaeverbeek M (2003) Alterations of red blood cell shape and sialic acid membrane content in septic patients. Crit Care Med 31:2156–2162PubMedCrossRefGoogle Scholar
  17. 17.
    Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Melot C, Vincent JL (1997) Erythropoietin response is blunted in critically ill patients. Intensive Care Med 23:159–162PubMedCrossRefGoogle Scholar
  18. 18.
    Krafte-Jacobs B (1997) Anemia of critical illness and erythropoietin deficiency. Intensive Care Med 23:137–138PubMedCrossRefGoogle Scholar
  19. 19.
    Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG (2001) Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 16:36–41PubMedCrossRefGoogle Scholar
  20. 20.
    Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288:2827–2835PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Timothy S. Walsh
    • 1
  • Ezz-el-din Saleh
    • 1
  • Robert J. Lee
    • 2
  • D. Brian McClelland
    • 3
  1. 1.Anaesthetics, Critical Care and Pain MedicineNew Edinburgh Royal InfirmaryEdinburghUK
  2. 2.Medical Statistics UnitEdinburgh UniversityEdinburghUK
  3. 3.Effective Use of Blood GroupScottish National Blood Transfusion ServiceEdinburghUK

Personalised recommendations